肿瘤标志物检验在肺癌诊断中的临床价值分析  

Analysis of clinical value of tumor marker test in diagnosis of lung cancer

作　　者：刘洋[1] LIU Yang(Department of Laboratory,Huludao Central Hospital,Liaoning Province,Huludao,Liaoning,121005,China)

机构地区：[1]辽宁省葫芦岛市中心医院检验科,辽宁葫芦岛121005

出　　处：《当代医学》2021年第36期97-98,共2页Contemporary Medicine

摘　　要：目的分析肿瘤标志物检验在肺癌诊断中的临床价值。方法选取2017年12月至2019年7月本院收治的38例肺癌患者作为肺癌组,选取同期收治的40例肺部良性病变患者作为良性组,另选取同期40名健康体检者作为对照组。3组均接受肿瘤标志物检验,比较3组检测结果。结果肺癌组CEA、NSE、CA125、CYFRA21-1水平均高于良性组、对照组,差异有统计学意义(P<0.05);良性组CEA、NSE、CA125、CYFRA21-1水平均高于对照组,但组间比较差异无统计学意义。肺癌组CEA、NSE、CA125、CYFRA21-1阳性率均高于良性组、对照组,差异有统计学意义(P<0.05)。结论肿瘤标志物检验在肺癌诊断中的应用价值较高,值得临床推广应用。Objective To analyze the clinical value of tumor marker test in the diagnosis of lung cancer.Methods 38 lung cancer patients admitted to our hospital from December 2017 to July 2019 were select as the lung cancer group,40 patients with benign lung lesions admitted in the same period were selected as the benign group,and 40 healthy patients in the same period were selected as the control group.All groups were tested for tumor markers,and the test results of the three groups were compared.Results The levels of CEA,NSE,CA125 and CYFRA21-1 in the lung cancer group were higher than those in the benign group and the control group,and the difference was statistically significant(P<0.05);the levels of CEA,NSE,CA125 and CYFRA21-1 in the benign group were higher than those in the control group,but the difference between the groups was not statistically significant.The positive rates of CEA,NSE,CA125,and CYFRA21-1 in the lung cancer group were higher than those in the benign group and the control group,and the difference was statistically significant(P<0.05).Conclusion Tumor marker test has high application value in the diagnosis of lung cancer,and it is worthy of clinical application.

关 键 词：肿瘤标志物 检验 肺癌 诊断 临床价值 

分 类 号：R734.2[医药卫生—肿瘤]